<DOC>
	<DOC>NCT01006161</DOC>
	<brief_summary>Given the strong inhibition of SCH 527123 on neutrophil migration to sites of inflammation, there is a theoretical reason for its use in patients with severe asthma where neutrophils are thought to play a significant role in the pathophysiology of the disease.</brief_summary>
	<brief_title>Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Subject must have severe asthma, be at least 18 to less than or equal to 70 years of age, of either sex, and any race. Subject who has been diagnosed with COPD or any other clinically relevant lung disease, other than asthma (eg, cystic fibrosis, pulmonary fibrosis, bronchiectasis).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>